Publicacions en col·laboració amb investigadors/es de Gdańsk Medical University (4)

2024

  1. ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options

    Annals of Hematology, Vol. 103, Núm. 7, pp. 2299-2310

2021

  1. Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial

    Leukemia, Vol. 35, Núm. 5, pp. 1344-1355

2018

  1. Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study

    Journal of Cancer Research and Clinical Oncology, Vol. 144, Núm. 5, pp. 945-954

2017

  1. Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: Results from the ENESTfreedom study

    Leukemia, Vol. 31, Núm. 7, pp. 1525-1531